144 related articles for article (PubMed ID: 11778258)
21. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
[TBL] [Abstract][Full Text] [Related]
22. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
23. [Changes of leukotriene B4 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and the effects of theophylline].
Ding YL; Yao WZ; Liu Z; Wang YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):441-4. PubMed ID: 16115390
[TBL] [Abstract][Full Text] [Related]
24. Relationship between airway colonization, inflammation and exacerbation frequency in COPD.
Tumkaya M; Atis S; Ozge C; Delialioglu N; Polat G; Kanik A
Respir Med; 2007 Apr; 101(4):729-37. PubMed ID: 17002892
[TBL] [Abstract][Full Text] [Related]
25. [Detection of TNF-alpha and NCF in the serum and BALF of patients with sarcoidosis and evaluate their clinical significance].
Li Z; Chen W; Hou X; Yu R
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jan; 22(1):37-9. PubMed ID: 11812354
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokines.
Schmidt-Ioanas M; Pletz MW; de Roux A; Lode H
Respir Med; 2006 Apr; 100(4):639-47. PubMed ID: 16199149
[TBL] [Abstract][Full Text] [Related]
27. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
[TBL] [Abstract][Full Text] [Related]
28. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
29. [Elevated substance P content in sputum and plasma in patients with COPD and its relationship with FEV1/FVC].
Tian L; Cai L; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):138-40. PubMed ID: 11778483
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-{alpha} rs361525 polymorphism is associated with increased local production and downstream inflammation in chronic obstructive pulmonary disease.
Sapey E; Wood AM; Ahmad A; Stockley RA
Am J Respir Crit Care Med; 2010 Jul; 182(2):192-9. PubMed ID: 20299531
[TBL] [Abstract][Full Text] [Related]
31. Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease.
Moermans C; Heinen V; Nguyen M; Henket M; Sele J; Manise M; Corhay JL; Louis R
Cytokine; 2011 Nov; 56(2):298-304. PubMed ID: 21880505
[TBL] [Abstract][Full Text] [Related]
32. Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease.
Zeng M; Wen Y; Liu LY; Wang H; Guan KP; Huang X
Respiration; 2009; 78(4):399-403. PubMed ID: 19339767
[TBL] [Abstract][Full Text] [Related]
33. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis.
Erdemir EO; Duran I; Haliloglu S
J Clin Periodontol; 2004 Feb; 31(2):99-104. PubMed ID: 15016034
[TBL] [Abstract][Full Text] [Related]
34. [The effects of recombinant human tumor necrosis factor-Fc on pulmonary function in a rat model of chronic obstructive pulmonary disease].
Zhang C; Chen P; Cai S; Chen JB; Wu J
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):432-6. PubMed ID: 17673016
[TBL] [Abstract][Full Text] [Related]
35. Plasma levels of tumor necrotic factor-alpha and interleukin-6, -8 during orthotopic liver transplantation and their relations to postoperative pulmonary complications.
Wen XH; Kong HY; Zhu SM; Xu JH; Huang SQ; Chen QL
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):38-41. PubMed ID: 14969835
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effect of methoxyphenamine compound in rat model of chronic obstructive pulmonary disease.
Wang YH; Bai CX; Hong QY; Chen J
Acta Pharmacol Sin; 2003 Dec; 24(12):1324-7. PubMed ID: 14653967
[TBL] [Abstract][Full Text] [Related]
37. TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease.
Seifart C; Dempfle A; Plagens A; Seifart U; Clostermann U; Müller B; Vogelmeier C; von Wichert P
Tissue Antigens; 2005 Jan; 65(1):93-100. PubMed ID: 15663746
[TBL] [Abstract][Full Text] [Related]
38. [Body mass index and serum and sputum TNF-alpha levels relation in asthma and COPD].
Başyiğit I; Yildiz F; Yildirim E; Boyaci H; Ilgazli A
Tuberk Toraks; 2004; 52(3):256-61. PubMed ID: 15351939
[TBL] [Abstract][Full Text] [Related]
39. Can hypertonic saline inhalation influence preformed chemokine and mediator release in induced sputum of chronic obstructive pulmonary disease patients? Comparison with isotonic saline.
Cianchetti S; Bacci E; Bartoli ML; Ruocco L; Pavia T; Dente FL; Di Franco A; Vagaggini B; Paggiaro P
Clin Exp Allergy; 2007 Dec; 37(12):1819-26. PubMed ID: 17941910
[TBL] [Abstract][Full Text] [Related]
40. [The relationship between a decrease in fat mass and serum levels of TNF-alpha in patients with chronic obstructive pulmonary disease].
Yamamoto C; Yoneda T; Yoshikawa M; Fu A; Takenaka I; Kobayashi A; Okamura I; Okamoto Y; Tsukaguchi K; Narita N
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1191-5. PubMed ID: 9493445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]